SmartRent (NYSE:SMRT) Beats Q2 CY2026 Sales Expectations

SmartRent (NYSE:SMRT) reported Q2 CY2026 revenue of $39.84 million, up 4% year on year, beating analysts’ expectations by 0.6%. GAAP EPS was -$0.03, matching consensus. The company reported ARR of $64.5 million. Analysts forecast revenue growth of 21.3% over the next 12 months. Shares rose 1.4% to $1.07 after results.

Original reporting
Published Aug 5, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 1:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SmartRent (NYSE:SMRT) Beats Q2 CY2026 Sales Expectations — source image
Decision brief

The 30-second read

$SMRTNeutralMed
01

Why it matters

The quarter shows a narrow revenue and ARR beat, but profitability metrics remain weak, making the next catalyst likely tied to improving losses and operating leverage.

02

Market read

Traders get a fresh datapoint on Q2 revenue/ARR versus expectations and a same-day price reaction, but the profitability outlook remains the main uncertainty.

03

What to watch

ARR growth is highlighted, but the text also flags EBITDA miss and continued losses, implying traders should focus on margin trajectory rather than the headline beat.

Relevance 7/10Novelty 6/10Timing: post-Q2 results, same-day reaction reported

Background

SmartRent is a smart home devices and software provider focused on multifamily, SFR, and student housing, with revenue partly driven by recurring subscriptions/contracts.

Company-level read

Ticker impact

$SMRTNeutralMedium confidence
Context

SmartRent reported Q2 CY2026 revenue of $39.84M, up 4% YoY, topping expectations by 0.6%, with GAAP EPS -$0.03 in line.

Expected impact

Near-term upside bias from the revenue/ARR beat, but limited follow-through risk given ongoing losses and negative operating margin.

Evidence & confidence

The article provides a same-day stock move (+1.4% to $1.07) and highlights that EPS and EBITDA missed while margins remain negative, suggesting the market reaction may fade unless profitability improves.

Market effects

Reinforces that smart-home/multifamily tech names can show modest top-line growth via recurring revenue, but profitability remains the key swing factor.

No specific regional spillover described.

No global macro or cross-border catalyst described.

Counterpoint

The revenue beat may be less durable given the article’s note of annualized revenue declines over the last two years and still-negative operating margin.

Key entities

  • SmartRent

    Smart home devices and software provider reporting Q2 CY2026 results and ARR performance.

  • Wall Street estimates

    Consensus revenue and EPS benchmarks referenced for the quarter’s beat/miss assessment.

Related articles

$SMRTMed

SmartRent, Inc. (SMRT): Results of Operations and Financial Condition

SmartRent, Inc. (SMRT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 smrt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SmartRent Reports Second Quarter 2026 Financial Results Accelerating Revenue Growth Trend Supports March to One Million Installed Units Improving Profitability Powers Investment in Growth and Capital Returns Phoenix, Ariz., A

$DLXMed

Deluxe Q2 Earnings Call Highlights

Deluxe (NYSE:DLX) reported Q2 segment results, led by Data Solutions revenue up 21.4% to $82.3M and adjusted EBITDA of $18.1M. Merchant Services revenue rose 6.1% to $107.6M. Print revenue fell 4.3% to $235.9M. Deluxe closed its Celero acquisition on July 31 and raised 2026 guidance: revenue $2.095B-$2.12B, adj. EBITDA $455M-$475M, adj. EPS $3.60-$4.00, and FCF about $200M.

$NEOGMedAI 8/10

Neogen (NEOG) Q4 2026 Earnings Call Transcript

Neogen (NEOG) reported fiscal Q4 2026 revenue of $225.3 million, up 4.3% in core growth, led by Food Safety. Adjusted gross margin rose to 49.7% and adjusted EBITDA grew 12% to $45.4 million. FY2027 guidance: revenue $880-$885 million and adjusted EBITDA $180-$182 million. The company plans a 50% R&D increase and a $140 million genomics divestiture for debt reduction.

$FTSMed

Fortis (FTS) Q2 2026 Earnings Call Transcript

Fortis (FTS) reported Q2 2026 net earnings of C$396 million, up C$26 million year over year, and EPS of C$0.78. Capital expenditures were C$2.7 billion through June, with a C$5.6 billion 2026 plan. Management reiterated 4% to 6% dividend growth through 2030 and cited Tilbury LNG Phase 1B approval and a 9.75% ROE request in an Arizona rate case.

$ANMed

AutoNation (AN) Q2 2026 Earnings Call Transcript

AutoNation (AN) reported Q2 2026 adjusted diluted EPS of $5.56, up 2% year over year, with total revenue of $6.93 billion, essentially flat. After-sales gross profit was a record $607 million, and Customer Financial Services profitability rose to $2,800 per vehicle. ANF net income increased to $11 million and the portfolio grew to $2.67 billion. The company repurchased $457 million of shares and acquired four stores.

$DOCMed

Healthpeak Properties Q2 Earnings Call Highlights

Healthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.